查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1695028

2025年全球智慧药物传输系统市场报告

Smart Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年智慧药物输送系统市场规模将快速成长。到 2029 年，这一数字将成长至 310.1 亿美元，复合年增长率为 19.6%。预测期内的增长可归因于非传染性疾病负担的增加、对精准医疗的日益关注、预后诊断的增加、对非侵入性药物输送方法的需求的增加以及医疗保健支出的增加。预测期内的关键趋势包括小型化和微製造技术、材料科学的进步、人工智慧 (AI) 和机器学习 (ML) 的融合、奈米级药物传输系统的开发以及物联网和可穿戴技术的融合。

慢性病盛行率的不断上升预计将推动智慧药物输送系统市场的扩张。慢性病是长期健康状况，逐渐发展，通常由多种因素引起。这些疾病的盛行率不断上升，受到人口老化、环境因素和医疗保健机会不平等的影响。智慧药物输送系统透过提高药物疗效和增加患者依从性，为管理慢性疾病提供了一个有希望的解决方案。例如，根据美国医学图书馆－国家医学图书馆2023年1月发布的报告，预计到2050年，美国患有至少一种慢性病的人数将达到1.4266亿，比2020年的7152.2万人增长99.5%。因此，慢性病盛行率的上升正在推动智慧药物输送系统市场的成长。

智慧药物输送系统市场的关键参与者正致力于开发能够彻底改变药物管理的创新可重复使用药物输送设备。其中之一就是 Qfinity，一种可重复使用的药物传输装置，专为皮下自我给药而设计。与一次性使用不同，Qfinity 可用于多次注射，从而减少废弃物并提供环境效益。例如，捷普公司 (Jabil Inc.) 于 2022 年 5 月推出了 Qfinity。该设备每台可注射超过 100 次，并与各种预填充药筒相容。该设备不仅可以减少每次注射的碳排放，而且功能多样，可适应各种药物的体积和黏度。此外，连网版本 Qfinity+ 可透过内建感测器和电子设备远端监控患者照护和依从性，确保连接性且不影响易用性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球智慧型药物传输系统PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球智慧药物输送系统市场：成长率分析
  • 全球智慧药物传输系统市场表现：规模与成长，2019-2024
  • 全球智慧药物传输系统市场预测：规模与成长，2024-2029 年，2034 年
  • 全球智慧型药物传输系统总目标市场（TAM）

第六章市场区隔

  • 全球智慧药物传输系统市场（按产品、性能和预测）2019-2024 年、2024-2029 年、2034 年
  • 连接吸入器
  • 已连接的自动注射器
  • 可连接笔式註射器
  • 连网穿戴注射器
  • 附加元件感测器
  • 其他产品
  • 全球智慧型药物传输系统市场（依治疗领域、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 代谢紊乱
  • 神经系统疾病
  • 呼吸系统疾病
  • 荷尔蒙失调
  • 其他治疗领域
  • 全球智慧药物传输系统市场（按药物传输模式、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 注射剂
  • 吸入
  • 口服
  • 全球智慧型药物传输系统市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 居家护理
  • 门诊治疗环境
  • 其他最终用户
  • 全球智慧药物传输系统市场，按联网吸入器类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 干粉吸入器（DPI）
  • 定量喷雾吸入器（MDI）
  • 全球智慧型药物传输系统市场、连网自动注射器细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量自动注射器
  • 多剂量自动注射器
  • 全球智慧药物传输系统市场，依连网笔式註射器类型细分，效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 胰岛素笔注射器
  • 生物製药笔式註射器
  • 全球智慧药物传输系统市场、连网和穿戴式註射器细分（按类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 穿戴式胰岛素注射器
  • 输液帮浦 穿戴式註射器
  • 全球智慧型药物传输系统市场、附加附加元件细分、类型、效能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 血糖值监测感测器
  • 药物依从性感测器
  • 温度感测器
  • 全球智慧药物传输系统市场、其他产品细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 智慧注射器
  • 智慧型贴片
  • 智慧植入

第七章 区域和国家分析

  • 全球智慧型药物传输系统市场（按地区、绩效及预测）：2019-2024 年、2024-2029 年、2034 年
  • 全球智慧型药物传输系统市场（依国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 智慧药物输送系统市场：竞争格局
  • 智慧药物输送系统市场：公司简介
    • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Medtronic plc
  • Eli Lilly and Company
  • Amgen Inc
  • Novo Nordisk
  • Merck Group
  • Becton Dickinson and Company
  • Stryker Corporation
  • Baxter International Inc
  • Boston Scientific Corporation
  • Biogen Inc
  • Vertex Pharmaceuticals Incorporated
  • Phillips-Medisize Corporation
  • ResMed Inc
  • West Pharmaceutical Services Inc
  • Insulet Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年智慧药物输送系统市场：提供新机会的国家
  • 2029年智慧药物输送系统市场：细分市场将带来新机会
  • 2029年智慧药物传输系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r29006

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $12.65 billion in 2024 to $15.17 billion in 2025 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to increasing demand for drug delivery systems, rising patient compliance, rising prevalence of chronic diseases, increasing personalized medicine, and need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $31.01 billion in 2029 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to growing burden of non-communicable diseases, increased focus on precision medicine, the rise of theragnostic, growing demand for non-invasive drug delivery methods, and increasing healthcare expenditure. Major trends in the forecast period include miniaturization and microfabrication technologies, advancements in material science, integration of artificial intelligence (AI) and machine learning (ML), development of nano-sized drug delivery systems, and integration of IoT and wearable technology.

The growing prevalence of chronic diseases is expected to drive the expansion of the smart drug delivery systems market. Chronic diseases are long-term health conditions that develop gradually and are often caused by a combination of factors. The increasing prevalence of these diseases is influenced by aging populations, environmental factors, and disparities in healthcare access. Smart drug delivery systems present a promising solution for managing chronic diseases by improving medication effectiveness and enhancing patient adherence. For example, a January 2023 report from the National Library of Medicine, a US-based medical library, projects that by 2050, 142.66 million people in the United States will have at least one chronic illness, representing a 99.5% increase from 71.522 million in 2020. As a result, the rising prevalence of chronic diseases is driving growth in the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors; Other Products
  • 2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders; Other Therapeutic Areas
  • 3) By Drug Delivery Mode: Injectable; Inhalation; Oral
  • 4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings; Other End-Users
  • Subsegments:
  • 1) By Connected Inhalers: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs)
  • 2) By Connected Autoinjectors: Single-Dose Autoinjectors; Multi-Dose Autoinjectors
  • 3) By Connected Pen Injectors: Insulin Pen Injectors; Biologic Pen Injectors
  • 4) By Connected Wearable Injectors: Insulin Wearable Injectors; Infusion Pump Wearable Injectors
  • 5) By Add-On Sensors: Glucose Monitoring Sensors; Medication Adherence Sensors; Temperature Sensors
  • 6) By Other Products: Smart Syringes; Smart Patches; Smart Implants
  • Companies Mentioned: Pfizer Inc; Johnson & Johnson; Bayer AG; Abbott Laboratories; Novartis International AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Smart Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Smart Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Smart Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Smart Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Smart Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Smart Drug Delivery Systems Total Addressable Market (TAM)

6. Smart Drug Delivery Systems Market Segmentation

  • 6.1. Global Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Connected Inhalers
  • Connected Autoinjectors
  • Connected Pen Injectors
  • Connected Wearable Injectors
  • Add-On Sensors
  • Other Products
  • 6.2. Global Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metabolic Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Hormonal Disorders
  • Other Therapeutic Areas
  • 6.3. Global Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Injectable
  • Inhalation
  • Oral
  • 6.4. Global Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Care Settings
  • Other End-Users
  • 6.5. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • 6.6. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Autoinjectors
  • Multi-Dose Autoinjectors
  • 6.7. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Pen Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pen Injectors
  • Biologic Pen Injectors
  • 6.8. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Wearable Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Wearable Injectors
  • Infusion Pump Wearable Injectors
  • 6.9. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Add-On Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucose Monitoring Sensors
  • Medication Adherence Sensors
  • Temperature Sensors
  • 6.10. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smart Syringes
  • Smart Patches
  • Smart Implants

7. Smart Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Smart Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Smart Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Drug Delivery Systems Market

  • 8.1. Asia-Pacific Smart Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Drug Delivery Systems Market

  • 9.1. China Smart Drug Delivery Systems Market Overview
  • 9.2. China Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Drug Delivery Systems Market

  • 10.1. India Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Drug Delivery Systems Market

  • 11.1. Japan Smart Drug Delivery Systems Market Overview
  • 11.2. Japan Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Drug Delivery Systems Market

  • 12.1. Australia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Drug Delivery Systems Market

  • 13.1. Indonesia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Drug Delivery Systems Market

  • 14.1. South Korea Smart Drug Delivery Systems Market Overview
  • 14.2. South Korea Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Drug Delivery Systems Market

  • 15.1. Western Europe Smart Drug Delivery Systems Market Overview
  • 15.2. Western Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Drug Delivery Systems Market

  • 16.1. UK Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Drug Delivery Systems Market

  • 17.1. Germany Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Drug Delivery Systems Market

  • 18.1. France Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Drug Delivery Systems Market

  • 19.1. Italy Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Drug Delivery Systems Market

  • 20.1. Spain Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Drug Delivery Systems Market

  • 21.1. Eastern Europe Smart Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Drug Delivery Systems Market

  • 22.1. Russia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Drug Delivery Systems Market

  • 23.1. North America Smart Drug Delivery Systems Market Overview
  • 23.2. North America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Drug Delivery Systems Market

  • 24.1. USA Smart Drug Delivery Systems Market Overview
  • 24.2. USA Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Drug Delivery Systems Market

  • 25.1. Canada Smart Drug Delivery Systems Market Overview
  • 25.2. Canada Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Drug Delivery Systems Market

  • 26.1. South America Smart Drug Delivery Systems Market Overview
  • 26.2. South America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Drug Delivery Systems Market

  • 27.1. Brazil Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Drug Delivery Systems Market

  • 28.1. Middle East Smart Drug Delivery Systems Market Overview
  • 28.2. Middle East Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Drug Delivery Systems Market

  • 29.1. Africa Smart Drug Delivery Systems Market Overview
  • 29.2. Africa Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Smart Drug Delivery Systems Market Competitive Landscape
  • 30.2. Smart Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. Eli Lilly and Company
  • 31.3. Amgen Inc
  • 31.4. Novo Nordisk
  • 31.5. Merck Group
  • 31.6. Becton Dickinson and Company
  • 31.7. Stryker Corporation
  • 31.8. Baxter International Inc
  • 31.9. Boston Scientific Corporation
  • 31.10. Biogen Inc
  • 31.11. Vertex Pharmaceuticals Incorporated
  • 31.12. Phillips-Medisize Corporation
  • 31.13. ResMed Inc
  • 31.14. West Pharmaceutical Services Inc
  • 31.15. Insulet Corporation

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

34. Recent Developments In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Smart Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Smart Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Smart Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer